Latest Event Updates
Electrophoresis is a powerful and seemingly the most popular analytical technique in the field of micro-molecular separation and analysis. The rise in research activities, particularly in proteomics research activities undertaken in life sciences, biotechnology and pharmacy, has significantly contributed in fostering the global demand for electrophoresis instruments.
Browse full report with TOC: http://www.transparencymarketresearch.com/electrophoresis-equipment-supplies.html
The most common use of this technology can be seen in processes related to the separation and analysis of proteins, nucleic acids and sub-cellular particles such as small organelles and viruses. In chemical analysis, electrophoresis finds applications in processes such as sequencing of DNA, purifying proteins, peptides and other biomolecules. In clinical chemistry, it is used in examining patterns of amino acids, lipoproteins, enzymes and serum proteins in the body. Other applications of electrophoresis include analyzing organic and inorganic ions in environmental samples, commercial products and food products.
Geographically speaking, the US represents the largest market in the field of electrophoresis equipments and supplies; however, steady growth has also been seen in the Asia-Pacific market, which is forecast to grow at the rate of 4.80% during the years 2013 to 2019, owing to the overall development of research and healthcare facilities in these regions.
The market is segmented in two types of products: Gel electrophoresis systems and Capillary electrophoresis systems. Gel systems are being increasingly used in Genomics applications, adding further to the growth of this segment of products that is already the bigger share holder of the market. A rise in proteomics research activities has also led to an added demand for two dimensional (2D) gel based systems in the market.
On the other hand, Capillary Electrophoresis Equipment and Supplies Market are attributed as the fastest growing segment on this industry. These systems are gaining prominence as a result of their minimal solvent and sample requirement, complete automation, ease of miniaturization, capability for on-line detection, efficiency and resolution.
Other factors that have proved substantial in adding to the growth of electrophoresis systems include the increase in the demand for new innovative drugs and therapies, patent expiration of many specialty bestseller drugs that in turn leads invention of new drugs and new research projects revolving around proteins, genes and biomolecules.
The market for electrophoresis accessories has good demand for electrophoresis densitometers, DC supply and reagents. Of these, reagents have a hold on a major share within the market, followed by DC supply and electrophoresis densitometers. The key market players that continue to rule these markets include names like Agilent Technologies, Invitrogen, Lonza Group Ltd, Helena Laboratories Corp., Beckman Coulter, Bio-Rad Laboratories Inc., SERVA Electrophoresis GmbH, C.B.S Scientific, Dionex Corporation, among others.
The blood circulation inside our body takes place under specific conditions such as pressure and velocity, and is also dependent on our cardiac health, as well as physical activities. Blood pressure is defined as the pressure that is pumped out of the heart and taken into the arterial vessels. Typically, the velocity of blood flowing in our body is a measurable factor and can be determined using an appropriate blood pressure monitor. It is important to keep a check on our blood pressure level, whether in the hospital or at home. A blood pressure gauge meter is a simple way to measure the blood flow and performance of the pumps and the pipes in a human body.
Browse full Report with TOC: http://www.transparencymarketresearch.com/blood-flow-measurement-devices.html
Read through this comprehensive article below that gives you all the information about a variety of blood flow measurement devices available on the market and its significance in various applications and health conditions.
Blood Flow Measurement Devices – An Overview
An accurate measurement of the blood pressure inside the body is highly essential to ascertain the individuals of the blood pressure-related risks, symptoms, and to guide them in taking precautionary measures and management. A blood flow measurement device precisely serves the same purpose. These devices are implemented for measuring the volume rate of blood circulation in the blood vessels of the body system. In medical terms, the volume rate of blood flow is defined as the amount of blood flowing and passing through a specific cross section of a blood vessel in per unit time.
Blood flow measurement devices market are an extremely significant use for diagnosing different clinical vascular conditions including peripheral vascular diseases, arterial occlusion and diabetic micro and macro vascular problems. They are most sought after in applications such as cerebral blood flow measurement, skin testing, burn assessment, and more. These devices also record the vascular assessment data of the patients and help the physicians to maintain a balance between the demand of tissue oxygen and supply of those same patients.
Different Techniques to Measure Blood Pressure
The measuring of the amount of blood pressure does not pertain to a typical spot in the body, but can be performed anywhere along the entire blood circulation. It can be inside an artery, a heart chamber, within a vein, or within a capillary. There are two numbers in a blood pressure reading namely; systolic and diastolic with a typical reading of 120/80.
Unlike the primitive form of determining blood pressure using a catheter coupled with a closed chamber, now-a-days, clinicians are more concerned in performing a direct approach for measurement of pressure that is typically done by inserting a needle or a catheter into a blood vessel and record the data. In clinical practice, one can adopt an indirect method of measuring arterial pressure with the help of a manual sphygmomanometer. Some other methods include oscillometric technique, auscultatory method, ultrasound techniques, and the finger cuff method of Penaz.
Blood Flow Measurement Devices – Product Types
Considering the rise in geriatric population across the globe for minimally invasive procedures, a wide growth of the global blood flow measurement devices market has triggered the healthcare market. Today, the market for blood flow measurement devices includes a list of modern technical devices such as ultrasonic Doppler, laser Doppler, and electromagnetic blood flow measurement devices that caters services such as monitoring dermatology, peripheral vascular disease, diabetes, tumor monitoring, , intracranial monitoring (stroke & brain injury), and angiogenesis. Amongst the various diseases, the peripheral vascular disease accounts to be one of the biggest applications of blood flow measurement devices.
The use of blood flow measurement devices spreads across major regions such as Europe, North America, Asia and ROW (Rest of World). According to the transparency market research data regarding the end of the forecast period: Market Revenue for 2019 (USD) the proposed figure for the Blood Flow Measurement Devices market is stated to be 506.1 Million, with a CAGR of 8.7% for 2013–2019.
This article is intently written to explain the user the purpose and importance of using blood flow measurement devices in various healthcare conditions, and should not be used as a primary source for expert medical advice.
Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion.
Browse the full report with complete TOC: http://www.transparencymarketresearch.com/drug-device-combination.html
Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.
A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report.
Some of the major players profiled in this report are Boston Scientific Corporation, Abbott Laboratories, Allergan, Inc., Bayer Healthcare, Medtronic Inc., Bausch and Lomb, Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers for the global drug device combination products market. Government and NGO initiatives to promote drug delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug delivery technologies will serve as future growth opportunities for various drug device combination products. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the regulated products and thus complicating their approval process.
Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019
Transparency Market Research is Published new Market Report “ Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019,” .The market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.
Browse the full report with complete TOC: http://www.transparencymarketresearch.com/nanomedicine-market.html
The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.
The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.
However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.
Browse full report with TOC: Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019
North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.
Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.
The global nanomedicine market is categorized into the following segments:
Nanomedicine Market by Application
Nanomedicine Market by Geography
- North America
- Rest of the World (RoW)
Browse more market research reports: Transparency Market Research
Biopreservation Market Expected to Reach USD 5.74 Billion Globally in 2019: Transparency Market Research
According to a new market report published by Transparency Market Research “Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,“theglobal biopreservation market was valued at USD 1.95billion in 2012 and is expected to reach a value of USD 5.74 billion in 2019, growing at a CAGR of 16.7% from 2013 to 2019.
Browse Biopreservation Market Report with Full TOC: http://www.transparencymarketresearch.com/biopreservation-market.html
Extensive undertaking of biomedical research for new drugs and therapies will be one of the major factors responsible for growth of the global biopreservation market. Use of stem cells, tissues, plasma and DNA in the research sector also requires adequate storage facilities to accommodate the growing number of samples, while also maintaining their stability. Increase in sample size will lead to rise in demand for equipment such as freezer, refrigerator, liquid nitrogen and consumables, along with media and laboratory information management systems (LIMS).In addition, increase in funding aimed at boosting the capacity for sample storage by the government as well as private institutions will expedite the introduction of new biopreservation facilities and hence will drive growth of the overall market. Other driving factors include rising incidences of cardiovascular, orthopedic, oncological, autoimmune and infectious diseases, rising population awareness and increase in the number of individual sample contributions.
The global biopreservation market by product type was dominated by the equipment segment with a market share of approximately 82% in 2012,on account of thehigh cost and demand from biobanks and in-house preservation facilities of pharmaceutical and biotechnology companies. Increase in the sample size will also result in the need for capacity expansion and so will lead to increase in demand for biopreservation equipment. However, the global market for biopreservation consumables will be the fastest growing product segment. Factors such as increased research and transnational activities will have a high demand for biological samples, which would also increase the demand for media solutions. The home-brew media segment held the majority share of over 72%in the total market for biopreservation media in 2012.
Browse full PDF with TOC: Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
The global biopreservation market by applications was dominated by the biobanking segment with a market share of approximately 72% in 2012 on account of the high demand and usage of equipment, media and LIMS in this segment. Establishment of new biobanks during the forecast period will be one of the major growth factors for the biobanking application segment.However, the global regenerative medicine market for biopreservation will be the fastest growing application segment. A factor such as high prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cardiac disorders and tumors is driving the regenerative medicine market which will result in increased demand for biopreservation media and equipment.
North America dominated the biopreservation market in 2012 and is expected to maintain its position till 2019. However, the Asia-Pacific market is estimated to grow at a faster CAGR of 19.6% from 2013 to 2019, due to increase in biobanking and research activities in the region. The European market is expected to grow at a fairly higher rate than North America,on account of the constantly improving infrastructure, regulatory framework and new biobanking projects, especially in the Eastern European region.
Some of the key players in the global biopreservation market include Thermo Fisher Scientific Inc., VWR International LLC, BioLife Solutions Inc., BioCision LLC, Biomatrica Inc., Qiagen, LABVANTAGE Solutions Inc. and Panasonic Corporation.
- Liquid Nitrogen (LN2) Tanks
- Laboratory Information Management Systems (LIMS)
- Home-brew Media
- Pre-formulated Media
- Regenerative Medicine
- Drug Discovery
- North America
- Rest of the World
Hospital Acquired Disease Testing Market Expected to Reach USD 7.5 Billion Globally in 2019: Transparency Market Research
According to a new market report published by Transparency Market Research “Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019″, the global hospital acquired disease testing market was valued at USD 2.2 billionin 2012 and is expected to grow at a CAGR of 19.3% from 2013 to 2019, to reach an estimated value of USD 7.5 billion in 2019.
Browse the full report with TOC: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html
Nosocomial infections/hospital acquired diseases/hospital associated infections (HAI)form one of the critical areas of focus in the healthcare industry. Factors such as increasing prevalence of such conditions in neonatal and geriatric population, initiatives taken up by governments to manage nosocomial infections, increasing number of diseases that increases risk of hospital associated infections, and growing concerns about control and prevention of nosocomial infections worldwide will have a positive impact on the current hospital acquired disease testing industry.
The global hospital acquired disease testing market is segmented on the basis of type of infection and geography. Based on the different typesof infection,this market is classified into pneumonia, urinary tract infection, blood stream infection, surgical site associated infection, MRSA infection testing and others. The hospital acquired urinary tract infection diagnostics segment occupies the largest market share in this category as prevalence and morbidity rate of this condition, and the demand for diagnostic solutions for the same is the highest as compared to other hospital associated infections. It is expected that the global market for hospital associated urinary tract infection testing will reach USD 2,188.8 million in 2019 with the market growing at CAGR of 18.1%from 2013 to 2019. Furthermore, other testing solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America and other developing countries where the prevalence of such conditions is higher. It is expected that the market for surgical site infections will grow at a CAGR of 20.1%during the given period of forecast.
Geographically, United States and Canada together are the leaders in the global hospital acquired disease testing market with a combined market share (of the North American region) of 41.3% in 2012. Some of the major growth drivers for the North American nosocomial infection testing market include existence of highly developed healthcare infrastructure, high rate of implementation of healthcare guidelines given by regulatory and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and increasing awareness about these diseases and their prevention. The European Union considers infectious diseases as an increasing threat to the general public health; the public health system in this region is increasingly engaging itself in conducting dialogue between healthcare providers and medical practitioners for developing better, faster and cost effective methods for nosocomial infection management and prevention. Asian countries including China, Philippines and India are the most potential markets for such diagnostic and testing solutions owing to existence of factors such as higher population, poor hospital infrastructure, lack of adherence to sanitation procedures and therefor higher disease prevalence growth rates. UAE and African countries are some of the lucrative markets in the Rest of the World (RoW).
Molecular diagnostics solutions play a vital role in this market as they offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers. Some of the key market players contributing to this industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.
The global hospital acquired disease testing market is segmented as follows:
Hospital Acquired Disease Testing Market, by Infection Type
- Pneumonia infection
- Urinary tract infection
- Blood stream associated infection
- Surgical site infection
- MRSA infection
Hospital Acquired Disease Testing Market, by Geography
- North America
- Rest of the World